Acandis has announced the completion of its merger with Angionautix—a Spain- and Latin America-based neurovascular ...

Vital3D Technologies—a Lithuanian deep-tech company developing precision 3D microfabrication technology for medical devices, ...

Route 92 Medical today announced US Food and Drug Administration 510(k) clearance for the FreeClimb 46 catheter with Tenzing ...

Baystate Health (Springfield, USA) has announced it was previously selected to participate in a clinical trial intended to ...

Despite markedly reducing chronic subdural haematoma (cSDH) recurrence without significantly increasing overall adverse events, adjunctive middle meningeal artery embolisation (MMAE) was not ...

Perfuze has announced the publication of a peer-reviewed study in Clinical Neuroradiology comparing three aspiration ...

Anaconda Biomed today announced the closing of a US$56 million financing round with participation from new and existing investors. Proceeds will support product development and clinical work, ...

Hyperfine has announced that it has completed enrolment in the Contrast PMR study—a prospective, multicentre clinical study ...

As the stroke community continues to construct a greater understanding of the various factors that influence patient outcomes, many have called for more nuanced alternatives to the modified Rankin ...

Subsense—an artificial intelligence (AI)-native neurotechnology company developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs)—has announced a major expansion of its AI-driven ...

Cercare Medical has announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027 (29–30 April, Milan, Italy)—the company’s flagship ...

Earlier this month, at the 18th European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), the society introduced its new ...